Sign In

Sarah Hein

Entrepreneur in Residence at TMC ACT (Accelerator for Cancer Therapeutics)

Sarah Hein is an accomplished professional with a strong background in the biomedical industry. Currently serving as an Entrepreneur in Residence for the Texas Medical Center Accelerator for Cancer Therapeutics (TMC ACT), Sarah has a proven track record in startup leadership and operations. Prior to her current role, she co-founded Courier Therapeutics where she held the position of Vice President of Operations, contributing to its successful acquisition by Valo Health at a significant deal value of $510M. Sarah's experience also includes serving as the Director of Research at Resonant Therapeutics, specializing in antibody therapeutics platform technology. Her journey in the industry began as a Venture Fellow at Mercury Fund following the completion of her PhD in Molecular and Cellular Biology from Baylor College of Medicine. During her academic pursuits, Sarah was actively involved with Enventure and introduced the Foundations workshop series to foster entrepreneurship education within the TMC community.

Highlights

Jun 21 · linkedin

Incredibly excited to officially announce the launch of March Biosciences with the support of Portal Innovations, LLC and Texas Medical Center Innovation. John Flavin and the Portal team have been tremendous partners as we scale up.

We are very much looking forward to bringing this therapy to more patients in Phase 2 trials and beyond. Stay tuned!

Thank you to Kyle LaHucik for the great writeup and the Endpoints News team for the great writeup.

https://lnkd.in/du89maeP

Max Mamonkin Federica Giordano Gianina Varea Nick Pennebaker Thomas Luby John (JR) Reale Joseph Petrosino Omar Haneef Aaron Vernon Victoria (Tory) Lake, RAC Doris Sanchez Dr Alice Bexon Bambi Grilley, RPh, CIP, CCRC, CCRP, RAC Jason Bock

#biotech #venturecapital #houstonbusiness #cancerresearch #startups #celltherapy #lymphoma

Sarah Hein
Add to my network

Location

Houston, Texas, United States